Details
Stereochemistry | RACEMIC |
Molecular Formula | C26H30Cl2F3NO |
Molecular Weight | 500.424 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
InChI
InChIKey=FOHHNHSLJDZUGQ-UHFFFAOYSA-N
InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3
Molecular Formula | C26H30Cl2F3NO |
Molecular Weight | 500.424 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:43:15 UTC 2023
by
admin
on
Fri Dec 15 15:43:15 UTC 2023
|
Record UNII |
Q2OS4303HZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
P01BX01
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
||
|
FDA ORPHAN DRUG |
61791
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
||
|
NDF-RT |
N0000175482
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
HALOFANTRINE
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
DTXSID0023119
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
100000083941
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
C023768
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
m5900
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | Merck Index | ||
|
66051-63-6
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
SUPERSEDED | |||
|
274-104-1
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
DB01218
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
CHEMBL1107
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
69756-53-2
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
50749
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB07998MIG
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
Q2OS4303HZ
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
1350
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
37393
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
C65838
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
4749
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY | |||
|
Halofantrine
Created by
admin on Fri Dec 15 15:43:15 UTC 2023 , Edited by admin on Fri Dec 15 15:43:15 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |